Opiant
is a California-based pharmaceutical company that develops and researches medicines for the treatment of addictions and drug overdose... Read moreOpiant
is a California-based pharmaceutical company that develops and researches medicines for the treatment of addictions and drug overdose... Read more
News
May 23, 2023
Nasdaq
Opiant: FDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid Overdose
Mar 03, 2023
Citybizlist
Opiant: Indivior Completes Acquisition of Opiant Pharmaceuticals
Mar 02, 2023
MarketScreener
Opiant: Indivior completes acquisition of Opiant Pharmaceuticals
Jan 13, 2023
Seeking Alpha
Opiant: Opiant Pharmaceuticals: Nano-Cap Buyout With Interesting CVR Thrown In
Dec 05, 2022
GlobalNewswire
Press Release: Opiant : BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
Dec 01, 2022
GlobalNewswire
Press Release: Opiant : Lifshitz Law PLLC Announces Investigations of ELVT, OPNT, WAFD, and OYST
Nov 30, 2022
Global Legal Chronicle
Opiant: Indivior's $145 Million Acquisition of Opiant Pharmaceuticals
Nov 28, 2022
OINDPnews
Opiant: Opiant completes rolling NDA submission for OPNT003 intranasal nalmefene
Nov 22, 2022
GlobalNewswire
Press Release: Opiant : Opiant Pharmaceuticals Announces Completion of Rolling NDA Submission for OPNT003, Nasal Nalmefene, for Opioid Overdose
Nov 21, 2022
NewsFile
Press Release: Opiant : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Opiant Pharmaceuticals, Inc. Buyout
Opiant Competitors
1
2
3
4
5
6
7
8
9
10